Inventor · disambiguated record
Rajiv Indravadan Modi
Also filed as: MODI RAJIV INDRAVADAN
11 granted patents·4 pending applications·44 citations·filing 1998–2019
86Inventor score
Top patents by PatentIndex Score
15 records- 0177US8048434B2Vaccine adjuvantsCADILA PHARMACEUTICALS LTD·Filed 2006·Granted Nov 1, 2011·3 cites·22 claims
- 0275US9029567B2Hypoglycemic compoundsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted May 12, 2015·2 cites·8 claims
- 0373US8647643B2Farnesoid-X-receptor antagonist as a vaccine adjuvantKHAMAR BAKULESH MAFATLAL·Filed 2009·Granted Feb 11, 2014·1 cites·5 claims
- 0472US8277778B2Vaccine adjuvantsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 2, 2012·2 cites·15 claims
- 0570US9795659B2Pharmaceutical composition of killed cells with substantially retained immunogenicityKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 24, 2017·2 cites·4 claims
- 0663US9708258B2Indole 3-carbinol derivativesCADILA PHARMACEUTICALS LTD·Filed 2014·Granted Jul 18, 2017·2 cites·11 claims
- 0762US6306391B1Preparation of an oral pharmaceutical formulation containing an anti-infective agent and a microorganismCADILA PHARMACEUTICALS LTD·Filed 1998·Granted Oct 23, 2001·31 cites·16 claims
- 0858US9789187B2Stable pharmaceutical composition for atherosclerosisKHAMAR BAKULESH MAFATLAL·Filed 2010·Granted Oct 17, 2017·1 cites·11 claims
- 0958US8563517B2Dipeptidyl peptidase IV (DP-IV) compoundsKHAMAR BAKULESH MAFATLAL·Filed 2009·Granted Oct 22, 2013·0 cites·4 claims
- 1047US2010209394A1Mitogen activated protein kinase modulatorCADILA PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 1145US10882819B2Synthesis of novel intermediate(s) for preparing rivastigmineCADILA PHARMACEUTICALS LTD·Filed 2019·Granted Jan 5, 2021·0 cites·8 claims
- 1244US8153102B2Process for manufacturing pharmaceutical composition comprises of Mycobacterium w in the treatment of asthma (obstructive lung disease)MODI RAJIV INDRAVADAN·Filed 2003·Granted Apr 10, 2012·0 cites·21 claims
- 1344US2014045771A1Novel dipeptidyl peptidase iv (dp-iv) compoundsCADILA PHARMACEUTICALS LTD·Filed 2013·Application pending·0 cites
- 1442US2002025309A1Stable oral pharmaceutical formulation containing an anti-infective agent and a microorganismCADILA PHARMACEUTICALS LTD·Filed 2001·Application pending·0 cites
- 1538US2018042850A1Pharmaceutical Composition of Killed Cells with Substantially Retained ImmunogenicityCADILA PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajiv Indravadan Modi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →